BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.

NASDAQ: BBOT (BridgeBio Oncology Therapeutics)

Last update: 2 days ago, 11:55PM

8.81

0.13 (1.50%)

Previous Close 8.68
Open 8.80
Volume 101,404
Avg. Volume (3M) 279,691
Market Cap 705,089,216
Price / Book 1.77
52 Weeks Range
8.50 (-3%) — 14.87 (68%)
Earnings Date 6 May 2026

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bullish Mixed
Biotechnology (Global) Bullish Mixed
Stock BridgeBio Oncology Therapeutics Bullish -

AIStockmoo Score

2.4
Analyst Consensus 5.0
Insider Activity 3.0
Price Volatility 4.0
Technical Moving Averages 2.5
Technical Oscillators -2.5
Average 2.40

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BBOT 705 M - - 1.77
BNTX 22 B - - 1.08
MTSR 7 B - - -
LEGN 3 B - - 3.21
MAZE 2 B - - 6.50
PVLA 2 B - - 42.02

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Sector Healthcare
Industry Biotechnology

Ownership

Name Date Shares Held
Omega Fund Management, Llc 31 Dec 2025 3,289,661
Laurion Capital Management Lp 31 Dec 2025 1,464,938
52 Weeks Range
8.50 (-3%) — 14.87 (68%)
Price Target Range
23.00 (161%) — 29.00 (229%)
High 29.00 (HC Wainwright & Co., 229.17%) Buy
Median 24.00 (172.42%)
Low 23.00 (Stifel, 161.07%) Buy
Average 25.33 (187.51%)
Total 3 Buy
Avg. Price @ Call 11.88
Firm Date Target Price Call Price @ Call
HC Wainwright & Co. 06 Mar 2026 29.00 (229.17%) Buy 10.42
Stifel 11 Feb 2026 23.00 (161.07%) Buy 12.04
Raymond James 09 Jan 2026 24.00 (172.42%) Buy 13.19

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria